董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James A. Hayward | 男 | Chief Executive Officer, President and Chairman of the Board | 71 | 46.80万美元 | 473.26 | 2024-01-26 |
| Sanford R. Simon | 男 | Director | 81 | 15.13万美元 | 24.52 | 2024-01-26 |
| Joseph D. Ceccoli | 男 | Director | 61 | 15.50万美元 | 21.07 | 2024-01-26 |
| Robert B. Catell | 男 | Director | 87 | 15.25万美元 | 18.12 | 2024-01-26 |
| Elizabeth M. Schmalz Ferguson | 女 | Director | 72 | 15.38万美元 | 12.32 | 2024-01-26 |
| Yacov A. Shamash | 男 | Director | 74 | 16.25万美元 | 31.24 | 2024-01-26 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James A. Hayward | 男 | Chief Executive Officer, President and Chairman of the Board | 71 | 46.80万美元 | 473.26 | 2024-01-26 |
| Judith Murrah | 女 | Chief Operating Officer, Chief Information Officer and Secretary | 65 | 54.28万美元 | 37.57 | 2024-01-26 |
| Beth M. Jantzen | 女 | Chief Financial Officer | 48 | 50.10万美元 | 27.53 | 2024-01-26 |
| Clay Shorrock | 男 | Chief Legal Officer | 40 | 50.10万美元 | 未持股 | 2024-01-26 |
董事简历
中英对照 | 中文 | 英文- James A. Hayward
-
James A. Hayward自2006年3月17日起担任Applied DNA Sciences, Inc.首席执行官，自2007年6月12日起担任Applied DNA Sciences, Inc.总裁兼董事会主席。2005年10月5日起担任Applied DNA Sciences, Inc.的代理首席执行官。他还于2013年8月20日至2013年10月13日担任代理首席财务官。Hayward博士于1983年在纽约州立大学石溪分校获得分子生物学博士学位，并于2000年在同一学院获得名誉科学博士学位。他在上市公司的经历始于共同创立了英国最早的生物技术公司之一—— Biocompatibles。此后，Hayward博士在雅诗兰黛公司担任了五年的产品开发主管。1990年，他在Stony Brook创建了The Collaborative Group，这是一家为生物技术、制药和消费产品行业提供产品和服务的公司，他在Stony Brook担任了14年的董事长、总裁和首席执行官。在此期间，The Collaborative Group创建了多个业务，包括The Collaborative BioAlliance，一家人类基因产品的合同开发商和制造商，于2002年出售给陶氏化学；Collaborative Labs，一家护肤品和皮肤病成分的服务提供商和制造商，于2004年出售给Engelhard，现在是BASF。Hayward博士还担任Stony Brook大学制造和技术资源联盟艾瑞博德成员，Softheon公司和NeoMatrix制剂公司董事会成员。
James A. Hayward,has been Applied Dna Sciences, Inc. Chief Executive Officer since March 17, 2006, a director on the Board of Directors since September 28, 2005 and Applied Dna Sciences, Inc. President and the Chairman of the Board of Directors since June 12, 2007. He was previously Applied Dna Sciences, Inc. acting Chief Executive Officer since October 5, 2005. He also served as Acting Chief Financial Officer from August 20, 2013 through October 13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook ("Stony Brook") in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding of one of England's first biotechnology companies—Biocompatibles, Ltd. Following this, Dr. Hayward was at the Estee Lauder companies for five years, eventually becoming Head of Product Development. In 1990, he founded The Collaborative Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human protein products that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard (now BASF) in 2004. He is the winner of the first Helix Award from BIO and has been twice elected Entrepreneur of the Year by Inc. Magazine and the Long Island Technology Hall of Fame. He has served on the Boards of The Stony Brook Foundation, the NYS Research Foundation, and the NYS Regents Advisory Board. Dr. Hayward also serves on the advisory board of the Manufacturing and Technology Resource Consortium of Stony Brook University, and on the boards of Softheon Corporation, NeoMatrix Formulations, Inc. and the TNPO2 Foundation. - James A. Hayward自2006年3月17日起担任Applied DNA Sciences, Inc.首席执行官，自2007年6月12日起担任Applied DNA Sciences, Inc.总裁兼董事会主席。2005年10月5日起担任Applied DNA Sciences, Inc.的代理首席执行官。他还于2013年8月20日至2013年10月13日担任代理首席财务官。Hayward博士于1983年在纽约州立大学石溪分校获得分子生物学博士学位，并于2000年在同一学院获得名誉科学博士学位。他在上市公司的经历始于共同创立了英国最早的生物技术公司之一—— Biocompatibles。此后，Hayward博士在雅诗兰黛公司担任了五年的产品开发主管。1990年，他在Stony Brook创建了The Collaborative Group，这是一家为生物技术、制药和消费产品行业提供产品和服务的公司，他在Stony Brook担任了14年的董事长、总裁和首席执行官。在此期间，The Collaborative Group创建了多个业务，包括The Collaborative BioAlliance，一家人类基因产品的合同开发商和制造商，于2002年出售给陶氏化学；Collaborative Labs，一家护肤品和皮肤病成分的服务提供商和制造商，于2004年出售给Engelhard，现在是BASF。Hayward博士还担任Stony Brook大学制造和技术资源联盟艾瑞博德成员，Softheon公司和NeoMatrix制剂公司董事会成员。
- James A. Hayward,has been Applied Dna Sciences, Inc. Chief Executive Officer since March 17, 2006, a director on the Board of Directors since September 28, 2005 and Applied Dna Sciences, Inc. President and the Chairman of the Board of Directors since June 12, 2007. He was previously Applied Dna Sciences, Inc. acting Chief Executive Officer since October 5, 2005. He also served as Acting Chief Financial Officer from August 20, 2013 through October 13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook ("Stony Brook") in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding of one of England's first biotechnology companies—Biocompatibles, Ltd. Following this, Dr. Hayward was at the Estee Lauder companies for five years, eventually becoming Head of Product Development. In 1990, he founded The Collaborative Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human protein products that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard (now BASF) in 2004. He is the winner of the first Helix Award from BIO and has been twice elected Entrepreneur of the Year by Inc. Magazine and the Long Island Technology Hall of Fame. He has served on the Boards of The Stony Brook Foundation, the NYS Research Foundation, and the NYS Regents Advisory Board. Dr. Hayward also serves on the advisory board of the Manufacturing and Technology Resource Consortium of Stony Brook University, and on the boards of Softheon Corporation, NeoMatrix Formulations, Inc. and the TNPO2 Foundation.
- Sanford R. Simon
-
Sanford R. Simon自2006年3月17日起担任董事会成员。Simon博士自1997年以来一直担任Stony Brook生物化学、细胞生物学和病理学教授。他于1969年加入Stony Brook学院，担任助理教授，并于1975年晋升为副教授，终身任职。1995年至2004年，Simon博士是The Collaborative Group的董事会成员。从1967年到1969年，Simon博士是洛克菲勒大学的客座研究员。Simon博士于1963年获得哥伦比亚大学动物学和化学学士学位，1967年获得洛克菲勒大学生物化学博士学位，并在英国剑桥与诺贝尔奖获得者Max Perutz一起作为博士后研究员学习。他拥有一个活跃的研究实验室，研究癌症和炎症中细胞入侵的各个方面，利用小分子调节不同的细胞功能，以及新的药物输送策略；他还教授本科生、研究生、医学和牙科学生。
Sanford R. Simon,has been a member of the Board of Directors since March 17, 2006. Dr. Simon was a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook from 1969 to January 2022. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the board of directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969, Dr. Simon was a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963 and, a Ph.D. in Biochemistry from Rockefeller University in 1967, and he studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England. He has maintained an active research laboratory studying aspects of cell invasion in cancer and inflammation, the Applied Dna Sciences, Inc. es of small molecules in modulating diverse cell functions, and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical and dental students. - Sanford R. Simon自2006年3月17日起担任董事会成员。Simon博士自1997年以来一直担任Stony Brook生物化学、细胞生物学和病理学教授。他于1969年加入Stony Brook学院，担任助理教授，并于1975年晋升为副教授，终身任职。1995年至2004年，Simon博士是The Collaborative Group的董事会成员。从1967年到1969年，Simon博士是洛克菲勒大学的客座研究员。Simon博士于1963年获得哥伦比亚大学动物学和化学学士学位，1967年获得洛克菲勒大学生物化学博士学位，并在英国剑桥与诺贝尔奖获得者Max Perutz一起作为博士后研究员学习。他拥有一个活跃的研究实验室，研究癌症和炎症中细胞入侵的各个方面，利用小分子调节不同的细胞功能，以及新的药物输送策略；他还教授本科生、研究生、医学和牙科学生。
- Sanford R. Simon,has been a member of the Board of Directors since March 17, 2006. Dr. Simon was a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook from 1969 to January 2022. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the board of directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969, Dr. Simon was a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963 and, a Ph.D. in Biochemistry from Rockefeller University in 1967, and he studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England. He has maintained an active research laboratory studying aspects of cell invasion in cancer and inflammation, the Applied Dna Sciences, Inc. es of small molecules in modulating diverse cell functions, and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical and dental students.
- Joseph D. Ceccoli
-
Joseph D. Ceccoli于2014年12月3日被任命为董事会成员。自2010年以来，Ceccoli先生一直担任Biocogent，LLC“Biocogent”的Founder、总裁兼首席执行官，该公司是一家位于Stony Brook长岛高技术孵化器的生物科学公司。Biocogent专注于发明、开发和商业化皮肤活性分子和治疗产品，用于受管制的（非处方/医疗护理）、个人护理和消费品。在创办Biocogent公司之前，Ceccoli先生是BASF的全球运营总监，BASF是一家全球财富100强公司，也是世界上最大的全球化学品公司，他在2007年至2008年期间负责国内和海外业务部门的整合、运营和发展。在加入BASF之前，Ceccoli先生曾在总部位于美国的财富500强企业Engelhard公司担任总经理，并于2004年至2007年担任总部位于长岛的The Collaborative Group的首席运营官。Ceccoli先生拥有罗切斯特理工学院生物技术理学学士学位（“b.S。”），并在各种制药科学、乳液化学、工程和管理学科中接受过高级专业培训。他是众多专业组织的成员，如美国化学学会和化妆品类化学家协会。
Joseph D. Ceccoli,has been a member of the Board of Directors since December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC ("Biocogent"), a bioscience company located at the Stony Brook Long Island High Technology Incubator. Biocogent is focused on the invention, development and commercialization of skin-active molecules and treatment products Applied Dna Sciences, Inc. ed in regulated (over-the-counter / med-care), personal care and consumer products. Prior to starting Biocogent, Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company and the world's largest global chemical company, where he was responsible for the integration, operations and growth of domestic and overseas business units from 2007 to 2008. Prior to BASF, Mr. Ceccoli was a General Manager for Engelhard Corporation, a U.S.-based Fortune 500 company and chief operating officer of Long Island-based The Collaborative Group from 2004 to 2007. Mr. Ceccoli holds a Bachelor of Science ("B.S.") degree in Biotechnology from Rochester Institute of Technology and advanced professional training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous professional organizations such as the American Chemical Society and the Society of Cosmetic Chemists. Mr. Ceccoli has authored and co-authored 16 technical papers that have appeared in peer reviewed and industry specific journals and magazines and is inventor on 16 patents. - Joseph D. Ceccoli于2014年12月3日被任命为董事会成员。自2010年以来，Ceccoli先生一直担任Biocogent，LLC“Biocogent”的Founder、总裁兼首席执行官，该公司是一家位于Stony Brook长岛高技术孵化器的生物科学公司。Biocogent专注于发明、开发和商业化皮肤活性分子和治疗产品，用于受管制的（非处方/医疗护理）、个人护理和消费品。在创办Biocogent公司之前，Ceccoli先生是BASF的全球运营总监，BASF是一家全球财富100强公司，也是世界上最大的全球化学品公司，他在2007年至2008年期间负责国内和海外业务部门的整合、运营和发展。在加入BASF之前，Ceccoli先生曾在总部位于美国的财富500强企业Engelhard公司担任总经理，并于2004年至2007年担任总部位于长岛的The Collaborative Group的首席运营官。Ceccoli先生拥有罗切斯特理工学院生物技术理学学士学位（“b.S。”），并在各种制药科学、乳液化学、工程和管理学科中接受过高级专业培训。他是众多专业组织的成员，如美国化学学会和化妆品类化学家协会。
- Joseph D. Ceccoli,has been a member of the Board of Directors since December 3, 2014. Since 2010, Mr. Ceccoli has been the Founder, President and CEO of Biocogent, LLC ("Biocogent"), a bioscience company located at the Stony Brook Long Island High Technology Incubator. Biocogent is focused on the invention, development and commercialization of skin-active molecules and treatment products Applied Dna Sciences, Inc. ed in regulated (over-the-counter / med-care), personal care and consumer products. Prior to starting Biocogent, Mr. Ceccoli was Global Director of Operations for BASF Corporation, a global Fortune 100 company and the world's largest global chemical company, where he was responsible for the integration, operations and growth of domestic and overseas business units from 2007 to 2008. Prior to BASF, Mr. Ceccoli was a General Manager for Engelhard Corporation, a U.S.-based Fortune 500 company and chief operating officer of Long Island-based The Collaborative Group from 2004 to 2007. Mr. Ceccoli holds a Bachelor of Science ("B.S.") degree in Biotechnology from Rochester Institute of Technology and advanced professional training in various pharmaceutical sciences, emulsion chemistry, engineering and management disciplines. He is a member of numerous professional organizations such as the American Chemical Society and the Society of Cosmetic Chemists. Mr. Ceccoli has authored and co-authored 16 technical papers that have appeared in peer reviewed and industry specific journals and magazines and is inventor on 16 patents.
- Robert B. Catell
-
Robert B. Catell于2016年2月成为公司董事。Catell从1998年到2007年担任KeySpan Corporation and KeySpan Energy Delivery， 前身是Brooklyn Union Gas董事长和首席执行官。他于1958年加入Brooklyn Union Gas开始自己的职业生涯。National Grid于2007年收购KeySpan Corporation之后，Catell成为National Grid, U.S。董事长和National Grid plc. 副董事长。Catell现任Stony Brook University的先进能源研究和技术中心AERTC、New York State Smart Grid Consortium, Cristo Rey Brooklyn High School, Futures in Education Endowment Fund， 以及 New York Energy Policy Institute's Advisory Council （NYEPI）董事长。他还担任NYS Economic Development Power Allocation Board （EDPAB）董事以及多个其他企业、政府和非盈利组织董事。Catell持有City College of New York机械工程学士和硕士学位。
Robert B. Catell,has been a member of the Board of Directors since October 7, 2016. Mr. Catell serves as Chairman of the Advanced Energy Research and Technology Center (AERTC) at Stony Brook and the National Offshore Wind Research and Development Consortium (NOWRDC). He also serves on the board of several business and not-for-profit organizations, including Long Island Association (LIA), A+ Technology & Security Solutions, Inc., ThermoLift Inc., and Utility Technology Solutions (UTS). Mr. Catell was formerly Chairman and CEO of KeySpan Corporation and KeySpan Delivery (formerly Brooklyn Union Gas), Chairman of National Grid, U.S. and Deputy Chairman of National Grid plc, upon National Grid's acquisition of KeySpan, and has served on numerous boards including New York State Energy Research & Development Authority (NYSERDA.) Mr. Catell chaired the New York State Business Council from 2002 to 2003 and the Brooklyn Chamber of Commerce from 1994 to 1995. - Robert B. Catell于2016年2月成为公司董事。Catell从1998年到2007年担任KeySpan Corporation and KeySpan Energy Delivery， 前身是Brooklyn Union Gas董事长和首席执行官。他于1958年加入Brooklyn Union Gas开始自己的职业生涯。National Grid于2007年收购KeySpan Corporation之后，Catell成为National Grid, U.S。董事长和National Grid plc. 副董事长。Catell现任Stony Brook University的先进能源研究和技术中心AERTC、New York State Smart Grid Consortium, Cristo Rey Brooklyn High School, Futures in Education Endowment Fund， 以及 New York Energy Policy Institute's Advisory Council （NYEPI）董事长。他还担任NYS Economic Development Power Allocation Board （EDPAB）董事以及多个其他企业、政府和非盈利组织董事。Catell持有City College of New York机械工程学士和硕士学位。
- Robert B. Catell,has been a member of the Board of Directors since October 7, 2016. Mr. Catell serves as Chairman of the Advanced Energy Research and Technology Center (AERTC) at Stony Brook and the National Offshore Wind Research and Development Consortium (NOWRDC). He also serves on the board of several business and not-for-profit organizations, including Long Island Association (LIA), A+ Technology & Security Solutions, Inc., ThermoLift Inc., and Utility Technology Solutions (UTS). Mr. Catell was formerly Chairman and CEO of KeySpan Corporation and KeySpan Delivery (formerly Brooklyn Union Gas), Chairman of National Grid, U.S. and Deputy Chairman of National Grid plc, upon National Grid's acquisition of KeySpan, and has served on numerous boards including New York State Energy Research & Development Authority (NYSERDA.) Mr. Catell chaired the New York State Business Council from 2002 to 2003 and the Brooklyn Chamber of Commerce from 1994 to 1995.
- Elizabeth M. Schmalz Ferguson
-
ElizabethM.Schmalz Ferguson自2017年6月起担任董事会成员。她从2007年起，担任香料公司American Flavors&Fragrances的总裁。Ferguson女士还担任她自己的咨询公司Betsy Schmalz Ferguson&Associates的总裁。她曾担任雅诗兰黛（Est&233；e Lauder）企业产品开发高级副总裁。弗格森的职责包括监督公司一些最知名品牌的产品开发。随后，她担任Bath and Body Works和Victoria&8217；s Secret for the Limited的产品开发执行Vice President。弗格森女士在露华浓开始了她的高级管理生涯，负责Borghese，Ultima II和Prestige Fragrances等品牌的新产品开发。她是Cosmetic Executive Women的活跃成员。她在乔治亚法院大学获得心理学学士学位。
Elizabeth M. Schmalz Ferguson,has been a member of the Board of Directors since June 1, 2017. She has served as President of American Flavors & Fragrances LLC, a fragrance company, since 2003. Ms. Schmalz Shaheen also serves as President of her own consulting firm, Betsy Schmalz & Associates. She served as Senior Vice President of Corporate Product Development at Estée Lauder. Ms. Schmalz Shaheen's responsibilities included overseeing product development for some of the company's most prominent brands. Subsequently, she was Executive Vice President of Product Development at Bath and Body Works and Victoria's Secret for The Limited. Ms. Schmalz Shaheen started her senior management career at Revlon with responsibility for new product development for brands including Borghese, Ultima II and Prestige fragrances. She is an active member of Cosmetic Executive Women. She earned a bachelor's degree in psychology from Georgian Court University and serves on their Board of Trustees. Ms. Schmalz Shaheen's track record of accomplishments as a strategist and products leader within the cosmetics and personal care industries led the Board of Directors to conclude she should serve as a director of the Company. - ElizabethM.Schmalz Ferguson自2017年6月起担任董事会成员。她从2007年起，担任香料公司American Flavors&Fragrances的总裁。Ferguson女士还担任她自己的咨询公司Betsy Schmalz Ferguson&Associates的总裁。她曾担任雅诗兰黛（Est&233；e Lauder）企业产品开发高级副总裁。弗格森的职责包括监督公司一些最知名品牌的产品开发。随后，她担任Bath and Body Works和Victoria&8217；s Secret for the Limited的产品开发执行Vice President。弗格森女士在露华浓开始了她的高级管理生涯，负责Borghese，Ultima II和Prestige Fragrances等品牌的新产品开发。她是Cosmetic Executive Women的活跃成员。她在乔治亚法院大学获得心理学学士学位。
- Elizabeth M. Schmalz Ferguson,has been a member of the Board of Directors since June 1, 2017. She has served as President of American Flavors & Fragrances LLC, a fragrance company, since 2003. Ms. Schmalz Shaheen also serves as President of her own consulting firm, Betsy Schmalz & Associates. She served as Senior Vice President of Corporate Product Development at Estée Lauder. Ms. Schmalz Shaheen's responsibilities included overseeing product development for some of the company's most prominent brands. Subsequently, she was Executive Vice President of Product Development at Bath and Body Works and Victoria's Secret for The Limited. Ms. Schmalz Shaheen started her senior management career at Revlon with responsibility for new product development for brands including Borghese, Ultima II and Prestige fragrances. She is an active member of Cosmetic Executive Women. She earned a bachelor's degree in psychology from Georgian Court University and serves on their Board of Trustees. Ms. Schmalz Shaheen's track record of accomplishments as a strategist and products leader within the cosmetics and personal care industries led the Board of Directors to conclude she should serve as a director of the Company.
- Yacov A. Shamash
-
Yacov A. Shamash从2006年3月17日开始担任董事。Shamash博士担任石溪市纽约州立大学（State University of New York）的经济发展部副总裁。他从1992年开始担任该校工程与应用科学学院以及哈里曼管理与政策学院（Harriman School for Management and Policy）的院长，是该校纽约州无线技术卓越中心（New York State Center for Excellence in Wireless Technologies）的创始人。从1989年到1992年，Shamash博士开发并领导了NSF Industry与大学模拟与数字集成电路设计合作研究中心，从1985年到1992年，还担任华盛顿州立大学（Washington State University）电气与计算机工程部的主席。Shamash博士还担任Keytronic Corp.的董事。作为石溪市纽约州立大学（State University of New York）的经济发展部的副总裁，Shamash博士每天在大型和小型、地区和全球性企业的领导们方便时与其打交道，作为Key Tronic Corporation董事，通过为客户提供最高水平的说明，为市场和媒体提供最高水平的渠道，他在Key Tronic Corporation的业务开发中起着不可或缺的重要作用。
Yacov A. Shamash,has been a member of the Board of Directors since March 17, 2006. Dr. Shamash is a Professor of Electrical and Computer Engineering at Stony Brook, a position he has held since 1992. From 1992 to 2015, he was the Dean of Engineering and Applied Sciences, and from 1995 to 2004, Dr. Shamash was also the Dean of the Harriman School for Management and Policy at Stony Brook. He served as Vice President for Economic Development at Stony Brook from 2001to2019. He was founder of the New York State Center for Excellence in Wireless and Information Technology, and the New York State Center for Excellence in Advanced Energy Research, at Stony Brook. Dr. Shamash developed and directed the NSF Industry/University Cooperative Research Center for the Design of Analog/Digital Integrated Circuits from 1989 to 1992 and also served as Chairman of the Electrical and Computer Engineering Department at Washington State University from 1985 until 1992. Dr. Shamash serves on the board of directors of public companies Comtech Telecommunications Corp. and Keytronic Corp. He is on the boards of several not for profit organizations: the Long Island First Robotics and Listnet. Dr. Shamash holds a Ph.D. degree in Electrical Engineering from the Imperial College of Science and Technology in London, England. - Yacov A. Shamash从2006年3月17日开始担任董事。Shamash博士担任石溪市纽约州立大学（State University of New York）的经济发展部副总裁。他从1992年开始担任该校工程与应用科学学院以及哈里曼管理与政策学院（Harriman School for Management and Policy）的院长，是该校纽约州无线技术卓越中心（New York State Center for Excellence in Wireless Technologies）的创始人。从1989年到1992年，Shamash博士开发并领导了NSF Industry与大学模拟与数字集成电路设计合作研究中心，从1985年到1992年，还担任华盛顿州立大学（Washington State University）电气与计算机工程部的主席。Shamash博士还担任Keytronic Corp.的董事。作为石溪市纽约州立大学（State University of New York）的经济发展部的副总裁，Shamash博士每天在大型和小型、地区和全球性企业的领导们方便时与其打交道，作为Key Tronic Corporation董事，通过为客户提供最高水平的说明，为市场和媒体提供最高水平的渠道，他在Key Tronic Corporation的业务开发中起着不可或缺的重要作用。
- Yacov A. Shamash,has been a member of the Board of Directors since March 17, 2006. Dr. Shamash is a Professor of Electrical and Computer Engineering at Stony Brook, a position he has held since 1992. From 1992 to 2015, he was the Dean of Engineering and Applied Sciences, and from 1995 to 2004, Dr. Shamash was also the Dean of the Harriman School for Management and Policy at Stony Brook. He served as Vice President for Economic Development at Stony Brook from 2001to2019. He was founder of the New York State Center for Excellence in Wireless and Information Technology, and the New York State Center for Excellence in Advanced Energy Research, at Stony Brook. Dr. Shamash developed and directed the NSF Industry/University Cooperative Research Center for the Design of Analog/Digital Integrated Circuits from 1989 to 1992 and also served as Chairman of the Electrical and Computer Engineering Department at Washington State University from 1985 until 1992. Dr. Shamash serves on the board of directors of public companies Comtech Telecommunications Corp. and Keytronic Corp. He is on the boards of several not for profit organizations: the Long Island First Robotics and Listnet. Dr. Shamash holds a Ph.D. degree in Electrical Engineering from the Imperial College of Science and Technology in London, England.
高管简历
中英对照 | 中文 | 英文- James A. Hayward
James A. Hayward自2006年3月17日起担任Applied DNA Sciences, Inc.首席执行官，自2007年6月12日起担任Applied DNA Sciences, Inc.总裁兼董事会主席。2005年10月5日起担任Applied DNA Sciences, Inc.的代理首席执行官。他还于2013年8月20日至2013年10月13日担任代理首席财务官。Hayward博士于1983年在纽约州立大学石溪分校获得分子生物学博士学位，并于2000年在同一学院获得名誉科学博士学位。他在上市公司的经历始于共同创立了英国最早的生物技术公司之一—— Biocompatibles。此后，Hayward博士在雅诗兰黛公司担任了五年的产品开发主管。1990年，他在Stony Brook创建了The Collaborative Group，这是一家为生物技术、制药和消费产品行业提供产品和服务的公司，他在Stony Brook担任了14年的董事长、总裁和首席执行官。在此期间，The Collaborative Group创建了多个业务，包括The Collaborative BioAlliance，一家人类基因产品的合同开发商和制造商，于2002年出售给陶氏化学；Collaborative Labs，一家护肤品和皮肤病成分的服务提供商和制造商，于2004年出售给Engelhard，现在是BASF。Hayward博士还担任Stony Brook大学制造和技术资源联盟艾瑞博德成员，Softheon公司和NeoMatrix制剂公司董事会成员。
James A. Hayward,has been Applied Dna Sciences, Inc. Chief Executive Officer since March 17, 2006, a director on the Board of Directors since September 28, 2005 and Applied Dna Sciences, Inc. President and the Chairman of the Board of Directors since June 12, 2007. He was previously Applied Dna Sciences, Inc. acting Chief Executive Officer since October 5, 2005. He also served as Acting Chief Financial Officer from August 20, 2013 through October 13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook ("Stony Brook") in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding of one of England's first biotechnology companies—Biocompatibles, Ltd. Following this, Dr. Hayward was at the Estee Lauder companies for five years, eventually becoming Head of Product Development. In 1990, he founded The Collaborative Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human protein products that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard (now BASF) in 2004. He is the winner of the first Helix Award from BIO and has been twice elected Entrepreneur of the Year by Inc. Magazine and the Long Island Technology Hall of Fame. He has served on the Boards of The Stony Brook Foundation, the NYS Research Foundation, and the NYS Regents Advisory Board. Dr. Hayward also serves on the advisory board of the Manufacturing and Technology Resource Consortium of Stony Brook University, and on the boards of Softheon Corporation, NeoMatrix Formulations, Inc. and the TNPO2 Foundation.- James A. Hayward自2006年3月17日起担任Applied DNA Sciences, Inc.首席执行官，自2007年6月12日起担任Applied DNA Sciences, Inc.总裁兼董事会主席。2005年10月5日起担任Applied DNA Sciences, Inc.的代理首席执行官。他还于2013年8月20日至2013年10月13日担任代理首席财务官。Hayward博士于1983年在纽约州立大学石溪分校获得分子生物学博士学位，并于2000年在同一学院获得名誉科学博士学位。他在上市公司的经历始于共同创立了英国最早的生物技术公司之一—— Biocompatibles。此后，Hayward博士在雅诗兰黛公司担任了五年的产品开发主管。1990年，他在Stony Brook创建了The Collaborative Group，这是一家为生物技术、制药和消费产品行业提供产品和服务的公司，他在Stony Brook担任了14年的董事长、总裁和首席执行官。在此期间，The Collaborative Group创建了多个业务，包括The Collaborative BioAlliance，一家人类基因产品的合同开发商和制造商，于2002年出售给陶氏化学；Collaborative Labs，一家护肤品和皮肤病成分的服务提供商和制造商，于2004年出售给Engelhard，现在是BASF。Hayward博士还担任Stony Brook大学制造和技术资源联盟艾瑞博德成员，Softheon公司和NeoMatrix制剂公司董事会成员。
- James A. Hayward,has been Applied Dna Sciences, Inc. Chief Executive Officer since March 17, 2006, a director on the Board of Directors since September 28, 2005 and Applied Dna Sciences, Inc. President and the Chairman of the Board of Directors since June 12, 2007. He was previously Applied Dna Sciences, Inc. acting Chief Executive Officer since October 5, 2005. He also served as Acting Chief Financial Officer from August 20, 2013 through October 13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook ("Stony Brook") in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding of one of England's first biotechnology companies—Biocompatibles, Ltd. Following this, Dr. Hayward was at the Estee Lauder companies for five years, eventually becoming Head of Product Development. In 1990, he founded The Collaborative Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human protein products that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard (now BASF) in 2004. He is the winner of the first Helix Award from BIO and has been twice elected Entrepreneur of the Year by Inc. Magazine and the Long Island Technology Hall of Fame. He has served on the Boards of The Stony Brook Foundation, the NYS Research Foundation, and the NYS Regents Advisory Board. Dr. Hayward also serves on the advisory board of the Manufacturing and Technology Resource Consortium of Stony Brook University, and on the boards of Softheon Corporation, NeoMatrix Formulations, Inc. and the TNPO2 Foundation.
- Judith Murrah
Judith Murrah自2021年1月19日起担任Applied DNA Sciences, Inc.首席运营官，Applied DNA Sciences, Inc.自2013年6月1日起担任首席信息官，Applied DNA Sciences, Inc.自2017年12月22日起担任秘书。Murrah女士负责业务职能，包括发展关键的客户和合作伙伴关系、质量保证监督和业务管理以及信息技术战略。Murrah女士以前是Motorola Solutions的信息技术高级主管，该公司收购了她以前的公司Symbol Technologies。她在Motorola Solutions的职责包括监督全球IT项目管理办公室、财务和供应商业务以及质量保证。在Symbol，Murrah女士在产品线管理、全球客户销售、公司和营销传播以及IT领域担任领导职务。Murrah女士拥有哈佛商学院的工商管理硕士学位和罗德岛大学的工业工程学士学位。她是十四项美国专利的作者。Murrah女士是非营利组织ConnectToTech的联合创始人和总裁，ConnectToTech是让学生参与科学、技术、工程和数学学科的公认领导者，并在Middle Country Library Foundation董事会任职。Murrah女士被评为2005年和2006年长岛女性50强，并获得了首届2001年长岛科技女性领袖钻石奖。
Judith Murrah,has been Applied Dna Sciences, Inc. Chief Operating Officer since January 19, 2021, Applied Dna Sciences, Inc. Chief Information Officer since June 1, 2013, and Applied Dna Sciences, Inc. Secretary since December 22, 2017. Ms. Murrah is responsible for operations functions including production, quality, information technology and security, marketing, development of key customer and partner relationships, and field operations. Ms. Murrah was previously the Senior Director of Information Technology at Motorola Solutions, which had acquired her former firm, Symbol Technologies. Her role at Motorola Solutions included overseeing the global IT program management office, financial and supplier operations and quality assurance. At Symbol Technologies, Ms. Murrah held leadership positions in product line management, global account sales, corporate and marketing communications and IT. Ms. Murrah holds an MBA from Harvard Business School, and a B.S. in Industrial Engineering from the University of Rhode Island. She is an inventor on 14 U.S. patents. Ms. Murrah is active in Long Island's business and academic community. She has co-founded and volunteers with non-profits engaging students in science, technology, engineering, and math disciplines. She serves on the boards of the Middle Country (N.Y.) Library Foundation, the Tesla Science Center at Wardenclyffe, and Stony Brook University's Center for Corporate Education. Ms. Murrah was named to the Top 50 Women of Long Island Hall of Fame in 2023 and received the inaugural 2001 Diamond Award for Long Island Women Leaders in Technology.- Judith Murrah自2021年1月19日起担任Applied DNA Sciences, Inc.首席运营官，Applied DNA Sciences, Inc.自2013年6月1日起担任首席信息官，Applied DNA Sciences, Inc.自2017年12月22日起担任秘书。Murrah女士负责业务职能，包括发展关键的客户和合作伙伴关系、质量保证监督和业务管理以及信息技术战略。Murrah女士以前是Motorola Solutions的信息技术高级主管，该公司收购了她以前的公司Symbol Technologies。她在Motorola Solutions的职责包括监督全球IT项目管理办公室、财务和供应商业务以及质量保证。在Symbol，Murrah女士在产品线管理、全球客户销售、公司和营销传播以及IT领域担任领导职务。Murrah女士拥有哈佛商学院的工商管理硕士学位和罗德岛大学的工业工程学士学位。她是十四项美国专利的作者。Murrah女士是非营利组织ConnectToTech的联合创始人和总裁，ConnectToTech是让学生参与科学、技术、工程和数学学科的公认领导者，并在Middle Country Library Foundation董事会任职。Murrah女士被评为2005年和2006年长岛女性50强，并获得了首届2001年长岛科技女性领袖钻石奖。
- Judith Murrah,has been Applied Dna Sciences, Inc. Chief Operating Officer since January 19, 2021, Applied Dna Sciences, Inc. Chief Information Officer since June 1, 2013, and Applied Dna Sciences, Inc. Secretary since December 22, 2017. Ms. Murrah is responsible for operations functions including production, quality, information technology and security, marketing, development of key customer and partner relationships, and field operations. Ms. Murrah was previously the Senior Director of Information Technology at Motorola Solutions, which had acquired her former firm, Symbol Technologies. Her role at Motorola Solutions included overseeing the global IT program management office, financial and supplier operations and quality assurance. At Symbol Technologies, Ms. Murrah held leadership positions in product line management, global account sales, corporate and marketing communications and IT. Ms. Murrah holds an MBA from Harvard Business School, and a B.S. in Industrial Engineering from the University of Rhode Island. She is an inventor on 14 U.S. patents. Ms. Murrah is active in Long Island's business and academic community. She has co-founded and volunteers with non-profits engaging students in science, technology, engineering, and math disciplines. She serves on the boards of the Middle Country (N.Y.) Library Foundation, the Tesla Science Center at Wardenclyffe, and Stony Brook University's Center for Corporate Education. Ms. Murrah was named to the Top 50 Women of Long Island Hall of Fame in 2023 and received the inaugural 2001 Diamond Award for Long Island Women Leaders in Technology.
- Beth M. Jantzen
Beth M. Jantzen被任命为Applied DNA Sciences, Inc.的首席财务官，自2015年2月15日起生效。Jantzen女士自2013年5月起担任财务主任。在加入公司之前，Jantzen女士是Marcum LLP的高级经理，这是Applied DNA Sciences, Inc.的独立注册会计师事务所，从2000年1月至2014年6月23日，她管理多个项目，并专门研究SEC的政策、做法和程序，包括Sarbanes-Oxley法案的遵守情况。Jantzen女士拥有宾汉姆顿纽约州立大学会计学学士学位，同时也是注册会计师。
Beth M. Jantzen,has been Applied Dna Sciences, Inc. Chief Financial Officer since February 15, 2015. Previously, Ms. Jantzen held the position of Controller from May 2013 to her appointment as Chief Financial Officer. Prior to joining the Company, Ms. Jantzen was a senior manager at Marcum LLP, Applied Dna Sciences, Inc. independent registered accounting firm, from January 2000 until May 2013, where she managed multiple engagements and specialized in SEC policies, practices and procedures, including Sarbanes-Oxley compliance. Ms. Jantzen holds a B.S. in Accounting from the State University of New York at Binghamton and is also a Certified Public Accountant (CPA).- Beth M. Jantzen被任命为Applied DNA Sciences, Inc.的首席财务官，自2015年2月15日起生效。Jantzen女士自2013年5月起担任财务主任。在加入公司之前，Jantzen女士是Marcum LLP的高级经理，这是Applied DNA Sciences, Inc.的独立注册会计师事务所，从2000年1月至2014年6月23日，她管理多个项目，并专门研究SEC的政策、做法和程序，包括Sarbanes-Oxley法案的遵守情况。Jantzen女士拥有宾汉姆顿纽约州立大学会计学学士学位，同时也是注册会计师。
- Beth M. Jantzen,has been Applied Dna Sciences, Inc. Chief Financial Officer since February 15, 2015. Previously, Ms. Jantzen held the position of Controller from May 2013 to her appointment as Chief Financial Officer. Prior to joining the Company, Ms. Jantzen was a senior manager at Marcum LLP, Applied Dna Sciences, Inc. independent registered accounting firm, from January 2000 until May 2013, where she managed multiple engagements and specialized in SEC policies, practices and procedures, including Sarbanes-Oxley compliance. Ms. Jantzen holds a B.S. in Accounting from the State University of New York at Binghamton and is also a Certified Public Accountant (CPA).
- Clay Shorrock
Clay Shorrock自2021年4月1日起担任我们的首席法律官兼业务发展执行董事。Shorrock先生领导公司的法律、监管、知识产权和业务发展职能。Shorrock先生于2016年至2019年担任公司的内部总法律顾问兼知识产权法律顾问，此后担任外部总法律顾问兼知识产权法律顾问，然后回到公司的全职雇员。Shorrock先生一直致力于开发可用于供应链安全应用的Certifict®；平台，并将公司的核心PCR-制造能力扩展到生物疗法和诊断。他还领导了为公司获得紧急使用授权的努力’；S LineATM COVID-19检测试剂盒和随后的修正案，这些修正案提高了检测的效用。Shorrock先生拥有Franklin and Marshall College的生物学学士学位和Seton Hall University Law School的专注于知识产权的法学博士学位。
Clay Shorrock,has been Applied Dna Sciences, Inc. Chief Legal Officer and Executive Director of Business Development since April 2021. Mr. Shorrock leads Applied DNA's legal, regulatory, risk mitigation, intellectual property, and business development functions. Mr. Shorrock previously served as general and intellectual property counsel to Applied DNA from November 2016 through April 2019. Prior to rejoining the Company in April 2021, Mr. Shorrock was a member of the intellectual property groups of Florida-based Lowndes, Drosdick, Doster, Kantor & Reed, P.A. and Allen, Dyer, Doppelt & Gilchrist, P.A. Earlier in his career Mr. Shorrock was an associate at several New Jersey-based law firms where he focused on intellectual property and complex commercial transactions. Mr. Shorrock holds a B.A. in Biology from Franklin and Marshall College and a J.D. with a concentration in intellectual property from Seton Hall University Law School.- Clay Shorrock自2021年4月1日起担任我们的首席法律官兼业务发展执行董事。Shorrock先生领导公司的法律、监管、知识产权和业务发展职能。Shorrock先生于2016年至2019年担任公司的内部总法律顾问兼知识产权法律顾问，此后担任外部总法律顾问兼知识产权法律顾问，然后回到公司的全职雇员。Shorrock先生一直致力于开发可用于供应链安全应用的Certifict®；平台，并将公司的核心PCR-制造能力扩展到生物疗法和诊断。他还领导了为公司获得紧急使用授权的努力’；S LineATM COVID-19检测试剂盒和随后的修正案，这些修正案提高了检测的效用。Shorrock先生拥有Franklin and Marshall College的生物学学士学位和Seton Hall University Law School的专注于知识产权的法学博士学位。
- Clay Shorrock,has been Applied Dna Sciences, Inc. Chief Legal Officer and Executive Director of Business Development since April 2021. Mr. Shorrock leads Applied DNA's legal, regulatory, risk mitigation, intellectual property, and business development functions. Mr. Shorrock previously served as general and intellectual property counsel to Applied DNA from November 2016 through April 2019. Prior to rejoining the Company in April 2021, Mr. Shorrock was a member of the intellectual property groups of Florida-based Lowndes, Drosdick, Doster, Kantor & Reed, P.A. and Allen, Dyer, Doppelt & Gilchrist, P.A. Earlier in his career Mr. Shorrock was an associate at several New Jersey-based law firms where he focused on intellectual property and complex commercial transactions. Mr. Shorrock holds a B.A. in Biology from Franklin and Marshall College and a J.D. with a concentration in intellectual property from Seton Hall University Law School.